Post-translational modifications of RelB NF-κB subunit and associated functions

Cells

Volumn 5, Issue 2, 2016, Pages

  Baud, Véronique ^a   Collares, Davi ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cell motility; NF kappaB; NF B alternative pathway; Phosphorylation; Post translational modifications; RelB; SUMOylation; Ubiquitination

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERINE; THREONINE; TRANSCRIPTION FACTOR RELB; TYROSINE;

ACETYLATION; CELL SURVIVAL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; METHYLATION; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REPRESSOR GENE; REVIEW; SUMOYLATION; UBIQUITINATION;

EID: 85056746733     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells5020022     Document Type: Review

References (81)

1. Sen, R.; Baltimore, D. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 1986, 47, 921-928
2. Gerondakis, S.; Siebenlist, U. Roles of the NF-κB pathway in lymphocyte development and function. Cold Spring Harb. Perspect. Biol. 2010, 2, 1-29
3. Barnes, P.J.; Karin, M. Nuclear factor-κB-A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997, 336, 1066-1071
4. Baldwin, A.S. Regulation of cell death and autophagy by IKK and NF-κB: Critical mechanisms in immune function and cancer. Immunol. Rev. 2012, 246, 327-345
5. Rayet, B.; Gélinas, C. Aberrant Rel/NF-κB genes and activity in human cancer. Oncogene 1999, 18, 6938-6947
6. Naugler, W.E.; Karin, M. NF-κB and cancer-identifying targets and mechanisms. Curr. Opin. Genet. Dev. 2008, 18, 19-26
7. Baud, V.; Karin, M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 2009, 8, 33-40
8. Ben-Neriah, Y.; Karin, M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 2011, 12, 715-723
9. Nakanishi, C.; Toi, M. Nuclear factor factor-κB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer 2005, 5, 297-309
10. Oeckinghaus, A.; Ghosh, S. The NF-κB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 2009, 1, 1-14
11. Karin, M.; Ben-Neriah, Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 2000, 18, 621-663
12. Sun, S.C. The noncanonical NF-κB pathway. Immunol. Rev. 2012, 246, 125-140
13. Baud, V.; Jacque, E. The alternative NF-κB activation pathway and cancer: Friend or foe? Med. Sci. (Paris) 2008, 24, 1083-1088
14. Bours, V.; Azarenko, V.; Dejardinn, E.; Siebenlist, U. Human RelB (I-Rel) functions as a κ B site-dependent transactivating member of the family of Rel-related proteins. Oncogene 1994, 9, 1699-1702
15. Bours, V.; Burd, P.R.; Brown, K.; Villalobos, J.; Park, S.; Ryseck, R.P.; Bravo, R.; Kelly, K.; Siebenlist, U. A novel mitogen-inducible gene product related to p50/p105-NF-κ B participates in transactivation through a κB site. Mol. Cell Biol. 1992, 12, 685-695
16. Ryseck, R.P.; Bull, P.; Takamiya, M.; Bours, V.; Siebenlist, U.; Dobrzanski, P.; Bravo, R. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell Biol. 1992, 12, 674-684
17. Dobrzanski, P.; Ryseck, R.P.; Bravo, R. Both N-and C-terminal domains of RelB are required for full transactivation: Role of the N-terminal leucine zipper-like motif. Mol. Cell Biol. 1993, 13, 1572-1582
18. Jacque, E.; Tchenio, T.; Piton, G.; Romeo, P.H.; Baud, V. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc. Natl. Acad. Sci. USA 2005, 102, 14635-14640
19. Yilmaz, Z.B.; Weih, D.S.; Sivakumar, V.; Weih, F. RelB is required for Peyer’s patch development: Differential regulation of p52-RelB by lymphotoxin and TNF. Embo J. 2003, 22, 121-130
20. Derudder, E.; Dejardin, E.; Pritchard, L.L.; Green, D.R.; Korner, M.; Raud, V. RelB/p50 dimers are differentially regulated by tumor necrosis factor-α and lymphotoxin-β receptor activation: Critical roles for p100. J. Biol. Chem. 2003, 278, 23278-23284
21. Bonizzi, G.; Bebien, M.; Otero, D.C.; Johnson-Vroom, K.E.; Cao, Y.; Vu, D.; Jegga, A.G.; Aronow, B.J.; Ghosh, G.; Rickert, R.C.; et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. Embo J. 2004, 23, 4202-4210
22. Fusco, A.J.; Huang, D.B.; Miller, D.; Wang, V.Y.; Vu, D.; Ghosh, G. NF-κB p52:RelB heterodimer recognizes two classes of κB sites with two distinct modes. EMBO Rep. 2009, 10, 152-159
23. Natoli, G.; De Santa, F. Shaping alternative NF-κB-dependent gene expression programs: New clues to specificity. Cell Death Differ. 2006, 13, 693-696
24. Saccani, S.; Pantano, S.; Natoli, G. Modulation of NF-κB activity by exchange of dimers. Mol. Cell 2003, 11, 1563-1574
25. Wu, L.; D’Amico, A.; Winkel, K.D.; Suter, M.; Lo, D.; Shortman, K. RelB is essential for the development of myeloid-related CD8α-dendritic cells but not of lymphoid-related CD8α+ dendritic cells. Immunity 1998, 9, 839-847
26. Weih, F.; Carrasco, D.; Durham, S.K.; Barton, D.S.; Rizzo, C.A.; Ryseck, R.P.; Lira, S.A.; Bravo, R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κ B/Rel family. Cell 1995, 80, 331-340
27. Weih, F.; Warr, G.; Yang, H.; Bravo, R. Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 1997, 158, 5211-5218
28. Weih, D.S.; Yilmaz, Z.B.; Weih, F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 2001, 167, 1909-1919
29. Weih, F.; Durham, S.K.; Barton, D.S.; Sha, W.C.; Baltimore, D.; Bravo, R. Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. J. Immunol. 1996, 157, 3974-3979
30. Zhu, H.C.; Qiu, T.; Liu, X.H.; Dong, W.C.; Weng, X.D.; Hu, C.H.; Kuang, Y.L.; Gao, R.H.; Dan, C.; Tao, T. Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection. Cell Immunol. 2012, 274, 12-18
31. Vogel, C.F.; Wu, D.; Goth, S.R.; Baek, J.; Lollies, A.; Domhardt, R.; Grindel, A.; Pessah, I.N. Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation. Immunol. Cell Biol. 2013, 91, 568-575
32. Yoza, B.K.; Hu, J.Y.; Cousart, S.L.; Forrest, L.M.; McCall, C.E. Induction of RelB participates in endotoxin tolerance. J. Immunol. 2006, 177, 4080-4085
33. El Gazzar, M.; Yoza, B.K.; Hu, J.Y.Q.; Cousart, S.L.; McCall, C.E. Epigenetic Silencing of Tumor Necrosis Factor α during Endotoxin Tolerance. J. Biol. Chem. 2007, 282, 26857-26864
34. Chen, X.; El Gazzar, M.; Yoza, B.K.; McCall, C.E. The NF-κB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J. Biol. Chem. 2009, 284, 27857-27865
35. Xia, Y.; Pauza, M.E.; Feng, L.; Lo, D. RelB regulation of chemokine expression modulates local inflammation. Am. J. Pathol. 1997, 151, 375-387
36. Xia, Y.; Chen, S.; Wang, Y.; Mackman, N.; Ku, G.; Lo, D.; Feng, L. RelB modulation of IκBα stability as a mechanism of transcription suppression of interleukin-1α (IL-1α), IL-1β, and tumor necrosis factor α in fibroblasts. Mol. Cell Biol. 1999, 19, 7688-7696
37. Bakkar, N.; Ladner, K.; Canan, B.D.; Liyanarachchi, S.; Bal, N.C.; Pant, M.; Periasamy, M.; Li, Q.; Janssen, P.M.; Guttridge, D.C. IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. J. Cell Biol. 2012, 196, 497-511
38. Liu, T.F.; Yoza, B.K.; El Gazzar, M.; Vachharajani, V.T.; McCall, C.E. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 2011, 286, 9856-9864
39. Millet, P.; McCall, C.; Yoza, B. RelB: An outlier in leukocyte biology. J. Leukoc. Biol. 2013, 94, 941-951
40. Bellet, M.M.; Zocchi, L.; Sassone-Corsi, P. The RelB subunit of NFkB acts as a negative regulator of circadian gene expression. Cell Cycle 2012, 11, 3304-3311
41. Vogel, C.F.; Sciullo, E.; Li, W.; Wong, P.; Lazennec, G.; Matsumura, F. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol. Endocrinol. 2007, 21, 2941-3955
42. Baglole, C.J.; Maggirwar, S.B.; Gasiewicz, T.A.; Thatcher, T.H.; Phipps, R.P.; Sime, P.J. The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-κB family member RelB. J. Biol. Chem. 2008, 283, 28944-28957
43. Vaira, S.; Johnson, T.; Hirbe, A.C.; Alhawagri, M.; Anwisye, I.; Sammut, B.; O’Neal, J.; Zou, W.; Weilbaecher, K.N.; Faccio, R.; et al. RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation. Proc. Natl. Acad. Sci. USA 2008, 105, 3897-3902
44. Soysa, N.S.; Alles, N.; Weih, D.; Lovas, A.; Mian, A.H.; Shimokawa, H.; Yasuda, H.; Weih, F.; Jimi, E.; Ohya, K.; et al. The pivotal role of the alternative NF-κB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. J. Bone Miner. Res. 2010, 25, 809-818
45. Taniguchi, R.; Fukushima, H.; Osawa, K.; Maruyama, T.; Yasuda, H.; Weih, F.; Doi, T.; Maki, K.; Jimi, E. RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα. J. Biol. Chem. 2014, 289, 7349-7361
46. Stoffel, A.; Chaurushiya, M.; Singh, B.; Levine, A.J. Activation of NF-κB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis. Proc. Natl. Acad. Sci. USA 2004, 101, 9079-9084
47. Cormier, F.; Monjanel, H.; Fabre, C.; Billot, K.; Sapharikas, E.; Chereau, F.; Bordereaux, D.; Molina, T.J.; Avet-Loiseau, H.; Baud, V. Frequent engagement of RelB activation is critical for cell survival in multiple myeloma. PLoS ONE 2013, 8, e59127
48. Schwarzer, R.; Dorken, B.; Jundt, F. Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells. Leukemia 2012, 26, 806-813
49. Lwin, T.; Hazlehurst, L.A.; Li, Z.; Dessureault, S.; Sotomayor, E.; Moscinski, L.C.; Dalton, W.S.; Tao, J. Bone marrow stromal cells prevent apoptosis of lymphoma cells by up regulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-Hodgkin’s lymphoma cells. Leukemia 2007, 21, 1521-1531
50. Dos Santos, N.R.; Williame, M.; Gachet, S.; Cormier, F.; Janin, A.; Weih, D.; Weih, F.; Ghysdael, J. RelB-dependent stromal cells promote T-cell leukemogenesis. PLoS ONE 2008, 3, e2555
51. Xu, Y.; Josson, S.; Fang, F.; Oberley, T.D.; St Clair, D.K.; Wan, X.S.; Sun, Y.; Bakthavatchalu, V.; Muthuswamy, A.; St Clair, W.H. RelB enhances prostate cancer growth: Implications for the role of the nuclear factor-κB alternative pathway in tumorigenicity. Cancer Res. 2009, 69, 3267-3271
52. Wang, X.; Belguise, K.; Kersual, N.; Kirsch, K.H.; Mineva, N.D.; Galtier, F.; Chalbos, D.; Sonenshein, G.E. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat. Cell Biol. 2007, 9, 470-478
53. Lee, D.W.; Ramakrishnan, D.; Valenta, J.; Parney, I.F.; Bayless, K.J.; Sitcheran, R. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma. PLoS ONE 2013, 8, e57489
54. Shen, M.; Duan, X.; Zhou, P.; Zhou, W.; Wu, X.; Xu, S.; Chen, Y.; Tao, Z. Lymphotoxin β receptor activation promotes bladder cancer in a nuclear factor-κB-dependent manner. Mol. Med. Rep. 2015, 11, 783-790
55. Dimitrakopoulos, F.I.; Antonacopoulou, A.G.; Kottorou, A.; Vlotinou, H.; Panagopoulos, N.D.; Dougenis, D.; Scopa, C.; Papadaki, H.; Kalofonos, H.P. NSCLC and the alternative pathway of NF-κB: Uncovering an unknown relation. Virchows Arch. 2012, 460, 515-523
56. Josson, S.; Xu, Y.; Fang, F.; Dhar, S.K.; St Clair, D.K.; St Clair, W.H. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Oncogene 2006, 25, 1554-1559
57. Xu, Y.; Fang, F.; St Clair, D.K.; Josson, S.; Sompol, P.; Spasojevic, I.; St Clair, W.H. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1α,25-dihydroxyvitamin D(3) in prostate cancer cells. Mol. Cancer Ther. 2007, 6, 2048-2056
58. Cherry, E.M.; Lee, D.W.; Jung, J.U.; Sitcheran, R. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling. Mol. Cancer 2015, 14, 9
59. Demicco, E.G.; Kavanagh, K.T.; Romieu-Mourez, R.; Wang, X.; Shin, S.R.; Landesman-Bollag, E.; Seldin, D.C.; Sonenshein, G.E. RelB/p52 NF-κB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IκB-α expression and promote carcinogenesis of the mammary gland. Mol. Cell Biol. 2005, 25, 10136-10147
60. Mineva, N.D.; Wang, X.; Yang, S.; Ying, H.; Xiao, Z.X.; Holick, M.F.; Sonenshein, G.E. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J. Cell Physiol. 2009, 220, 593-599
61. Perkins, N.D. Post-translational modifications regulating the activity and function of the nuclear factor κB pathway. Oncogene 2006, 25, 6717-6830
62. Huang, B.; Yang, X.D.; Lamb, A.; Chen, L.F. Posttranslational modifications of NF-κB: Another layer of regulation for NF-κB signaling pathway. Cell Signal 2010, 22, 1282-1290
63. Calao, M.; Burny, A.; Quivy, V.; Dekoninck, A.; Van Lint, C. A pervasive role of histone acetyltransferases and deacetylases in an NF-κB-signaling code. Trends Biochem. Sci. 2008, 33, 339-349
64. Lu, T.; Stark, G.R. NF-κB: Regulation by Methylation. Cancer Res. 2015, 75, 3692-3695
65. Schmukle, A.C.; Walczak, H. No one can whistle a symphony alone-How different ubiquitin linkages cooperate to orchestrate NF-κB activity. J. Cell Sci. 2012, 125, 549-559
66. Sasaki, K.; Iwai, K. Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system. Immunol. Rev. 2015, 266, 175-189
67. Mabb, A.M.; Miyamoto, S. SUMO and NF-κB ties. Cell Mol. Life Sci. 2007, 64, 1979-1996
68. Smale, S.T. Hierarchies of NF-κB target-gene regulation. Nat. Immunol. 2011, 12, 689-694
69. Msaki, A.; Sánchez, A.M.; Koh, L.F.; Barré, B.; Rocha, S.; Perkins, N.D.; Johnson, R.F. The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration. Mol. Biol. Cell 2011, 22, 3032-3040
70. Lu, X.; Yarbrough, W.G. Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer. Cytokine Growth Factor Rev. 2015, 26, 7-13
71. Marienfeld, R.; Berberich-Siebelt, F.; Berberich, I.; Denk, A.; Serfling, E.; Neumann, M. Signal-specific and phosphorylation-dependent RelB degradation: A potential mechanism of NF-κB control. Oncogene 2001, 20, 8142-8147
72. Maier, H.J.; Marienfeld, R.; Wirth, T.; Baumann, B. Critical role of RelB serine 368 for dimerization and p100 stabilization. J. Biol. Chem. 2003, 278, 39242-39250
73. Leidner, J.; Palkowitsch, L.; Marienfeld, U.; Fischer, D.; Marienfeld, R. Identification of lysine residues critical for the transcriptional activity and polyubiquitination of the NF-κB family member RelB. Biochem. J. 2008, 416, 117-127
74. Authier, H.; Billot, K.; Derudder, E.; Bordereaux, D.; Rivière, P.; Rodrigues-Ferreira, S.; Nahmias, C.; Baud, V. IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors. Proc. Natl. Acad. Sci. USA 2014, 111, 14794-14799
75. Leidner, J.; Voogdt, C.; Niedenthal, R.; Möller, P.; Marienfeld, U.; Marienfeld, R.B. SUMOylation attenuates the transcriptional activity of the NF-κB subunit RelB. J. Cell Biochem. 2014, 115, 1430-1440
76. Hailfinger, S.; Nogai, H.; Pelzer, C.; Jaworski, M.; Cabalzar, K.; Charton, J.-E.; Guzzardi, M.; Décaillet, C.; Grau, M.; Dörken, B.; et al. Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines. Proc. Natl. Acad. Sci. USA 2011, 108, 14596-14601
77. Phosphosite. Available online: http://www.phosphosite.org (accessed on 28 April 2016).
78. Zinngrebe, J.; Montinaro, A.; Peltzer, N.; Walczak, H. Ubiquitin in the immune system. EMBO Rep. 2014, 15, 28-45
79. Puto, L.A.; Reed, J.C. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev. 2008, 22, 998-1010
80. Lee, S.T.; Li, Z.; Wu, Z.; Aau, M.; Guan, P.; Karuturi, R.K.; Liou, Y.C.; Yu, Q. Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. Mol. Cell 2011, 43, 798-810
81. Gill, G. SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? Genes Dev. 2004, 18, 2046-2059